TELIX PHARMACEUTICALS LIMITED

2.04%

$15.38

Market Cap $5.320B

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

PIONEER LITHIUM

Pioneer Minerals (ASX: PMM) stands as a leading Australian exploration firm spearheading lithium exploration and development within Canada.

Latest Threads

Tag

Subject

TLX

Ann: Telix Refinances Convertible Bonds

07:38

7.7K

07:38

Last post ejjwj

7.7K

TLX

Ann: Telix Investor Presentation April 2026

14/04/26

2.4K

14/04/26

Last post Alex.shipway

2.4K

TLX

Telix ASX TLX Breaking News & Current Commentary

137 138 139

14/04/26

8.3K

2.9M

14/04/26

Last post iamagenius

8.3K

2.9M

TLX

TLX Chart

34 35 36

14/04/26

2.1K

839K

14/04/26

Last post Drian

2.1K

839K

TLX

Ann: Telix and Regeneron Announce Radiopharma Collaboration

14/04/26

23K

14/04/26

Last post Roger10

23K

TLX

Ann: Ceasing to be a substantial holder

10/04/26

490

10/04/26

Last post

ASX News

490

TLX

Industry Analysis

10/04/26

3.0K

10/04/26

Last post pfuzzy

3.0K

TLX

Ann: FDA Accepts NDA for TLX101-Px (Pixclara)

10/04/26

11K

10/04/26

Last post AntimonyX

11K

See All Discussions

Timeline

Telix Investor Presentation April 2026
14 Apr 17:08	Share

Telix Refinances Convertible Bonds
14 Apr 16:54	Share

Telix and Regeneron Announce Radiopharma Collaboration
13 Apr 08:27	Share

Ceasing to be a substantial holder
10 Apr 17:01	Share

FDA Accepts NDA for TLX101-Px (Pixclara)
10 Apr 08:26	Share

Becoming a substantial holder
09 Apr 16:12	Share

Notification regarding unquoted securities - TLX
09 Apr 10:00	Share

Application for quotation of securities - TLX
09 Apr 09:57	Share

Telix Strengthens Board with Further Director Appointments
09 Apr 08:23	Share

Ceasing to be a substantial holder from CGF
07 Apr 16:35	Share

Q1 2026 Strong Revenue Growth and Tx Pipeline Advancement
07 Apr 08:28	Share

Ceasing to be a substantial holder
02 Apr 16:18	Share

Telix Appoints David Gill as Non-Executive Director
02 Apr 09:52	Share

Change in substantial holding
20 Mar 15:15	Share

Notification regarding unquoted securities - TLX
20 Mar 08:23	Share

Appendix 3Y Change in Director Interests - C Behrenbruch
18 Mar 08:24	Share

Notification of cessation of securities - TLX
18 Mar 08:24	Share

Becoming a substantial holder
17 Mar 17:32	Share

Telix Resubmits NDA to FDA for Pixclara Brain Cancer Imaging
16 Mar 08:19	Share

Becoming a substantial holder from CGF
12 Mar 16:23	Share

Notification of cessation of securities - TLX
12 Mar 08:30	Share

Application for quotation of securities - TLX
12 Mar 08:30	Share

ProstACT Global Phase 3 (Part 1) Results Presentation
10 Mar 08:24	Share

ProstACT Global Phase 3 (Part 1) Achieves Primary Objectives
10 Mar 08:24	Share

Pending Release of Shares from Voluntary Escrow
09 Mar 08:19	Share

Change in substantial holding
06 Mar 19:30	Share

Application for quotation of securities - TLX
05 Mar 08:56	Share

Appendix 4G and 2025 Corporate Governance Statement
20 Feb 08:54	Share

2025 Full Year Results Presentation
20 Feb 08:53	Share

2025 Full Year Results Announcement
20 Feb 08:53	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last $15.38		Change -0.320(2.04%)		Mkt cap ! $5.320B

Open	High	Low	Volume
$15.95	$15.97	$15.23	1.85M

Buyers (Bids)

Vol.	Price($)
732	$15.42

Sellers (Offers)

Price($)	Vol.
$15.46	1374

Last trade - 16.30pm 14/04/2026 (20 minute delay)

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED

Latest Threads

Is Klevo Quietly Building the Rails for a New Digital Rewards Economy?

Timeline

Featured News

Latest Articles

Telix jumps on maiden Chinese application for prostate imaging agent, but short selling increasing

Telix Pharma’s (ASX:TLX) got the Chinese market locked in its sights with a maiden application for Illuccix, a prostate cancer imaging agent, now lodged with (and accepted by) the National Medical Products Application (NMPA). Worth noting is this is just an acceptance of the appli...

More pain for Telix after PET scan agent knocked back by FDA

Telix (ASX:TLX) has experienced a jolt in its recovery after its quarterly – now, the FDA has knocked back an investigational PET scan agent.

Telix sinks as US regulator SEC issues subpoena over claims

Telix Pharma (ASX:TLX), the ASX listed healthcare major that once almost listed on the NASDAQ outright before...

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News